Protein C replacement in severe meningococcemia: rationale and clinical experience. - Wikidata - awgldk - TriplyDB

Protein C replacement in severe meningococcemia: rationale and clinical experience.

Protein C replacement in severe meningococcemia: rationale and clinical experience.

http://www.wikidata.org/entity/Q34219618

about

Prospects for vaccine prevention of meningococcal infection Meningococcal disease: treatable but still terrifying.Drotrecogin alfa: a new approach in the treatment of severe sepsis.Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis.Drotrecogin alfa (activated) in the treatment of severe sepsis.Neonatal purpura fulminans secondary to group B streptococcal infection.The role of protein C in sepsis.An ADAM-10 dependent EPCR shedding links meningococcal interaction with endothelial cells to purpura fulminans.

P2860

Q24537338-4E0BC10B-267B-4AAD-BE0F-3CF27292EF52 Q34599526-49F996F0-A873-40B9-A732-409E699794A9 Q34779800-50C0FA3D-D061-45CE-A295-B5CD34A675A5 Q35059326-7C8F240F-070B-4248-96F7-2079B5C467E8 Q36607385-5EE4A941-9501-4C9C-84E8-E53CADD0F560 Q46330121-724E67A5-1D54-4A87-AA18-2965BE568DA8 Q46953002-7BBDBE94-E181-45FD-806E-82E77B34AF13 Q52431401-74139E77-2375-4C07-8AA7-2562C39D6BFB

P2860

Protein C replacement in severe meningococcemia: rationale and clinical experience.

http://www.wikidata.org/entity/Q34219618

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@ast

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@en

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@nl

type

label

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@ast

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@en

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@nl

prefLabel

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@ast

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@en

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@nl

P1433

Q34219618-7F58555D-3372-4E2D-A309-BC09AD656063

P1476

Q34219618-CBAAA615-52C2-4E5B-BD49-F9C747CACB8C

P2093

Q34219618-BDD6A86A-B728-438F-8A79-817C3B2E1AEB

Q34219618-D6E87511-57B5-4914-AC70-9E8A23F94791

Q34219618-E1A52916-F689-45B3-BCCC-7EDE57DE5EB2

P2860

Q34219618-018BE8F6-0FB1-48E6-8626-A1D6709BD7A5

Q34219618-064EDCFD-A65C-4AB5-8277-10C175238211

Q34219618-0F482B1C-4FD9-4F38-B8FA-F90AA80D899A

Q34219618-1D9199B5-40A0-4B6A-9412-0F741E8DC771

Q34219618-2C380A89-1436-48EA-8BDA-67B865C474D2

Q34219618-2EF5E9D6-67C4-4B00-8A7F-E6F1F6F51A95

Q34219618-319C9562-3DBD-438D-8388-702D8792CA83

Q34219618-327A4504-C822-4CA4-804D-C08B6CD1484D

Q34219618-33C49DF0-3928-4593-B5DD-95E302FD0096

Q34219618-3494326A-AF2A-4C97-A967-29C6F01C1A07

P304

Q34219618-8E6D5334-4B22-445B-AAE2-4E0D77D815A4

P31

Q34219618-1178aefd-4102-46d7-8626-fb51d4b643f2

Q34219618-D104272F-EF3D-4436-9CB9-190F45E50F81

P356

Q34219618-2510D06B-4D0D-4EC1-809C-19E30EF185A1

P407

Q34219618-8EF74E97-BE5D-4CD5-A7AF-271CCC1BC150

P433

Q34219618-A1C59D18-4406-4423-9C84-FD696D4CB1D6

P478

Q34219618-2741BCAC-10CF-47D2-95CB-4408CCC40AF8

P577

Q34219618-3DEB5714-179D-4538-AF01-4C7359D9E3E2

P5875

Q34219618-E4BA70C6-5B31-4117-97FE-14C936AD6266

P698

Q34219618-AEED1CBF-9BBB-47E6-94CB-1813859DA8B7

P356

P1433

Clinical Infectious Diseases

P1476

Protein C replacement in severe meningococcemia: rationale and clinical experience.

@en

P2093

Alberio L

http://www.w3.org/2001/XMLSchema#string

Esmon CT

http://www.w3.org/2001/XMLSchema#string

Lämmle B

http://www.w3.org/2001/XMLSchema#string

P2860

Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon

Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate

Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway

Replacement therapy with a monoclonal antibody purified protein C concentrate in newborns with severe congenital protein C deficiency

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

Epidemic meningococcemia and purpura fulminans with induced protein C deficiency.

Infectious purpura fulminans: diagnosis and treatment.

Update on meningococcal disease with emphasis on pathogenesis and clinical management

Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

P304

1338-1346

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/319995

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12031618

http://www.w3.org/2001/XMLSchema#string

P698

11303270

http://www.w3.org/2001/XMLSchema#string